At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.
Close
PRPH ProPhase Labs
Trading 12-23 11:59:53 EST
0.8403
-0.1297
-13.37%
High0.9000Low0.8050Vol1.03M
Open0.8421D1 Closing0.9700Amplitude9.79%
Mkt Cap4.85MTradable Cap3.60MTotal Shares5.77M
T/O878.15KT/O Rate23.93%Tradable Shares4.28M
P/B--ROE--EPS0.00
52wk High--52wk Low--P/E--
Dividend--Div.Yield--ROA--

Loading ...

NASDAQ TRADE HALT CONTINUES HALT NEWS PENDING AT 03:28 AM
Reuters  ·  12-21 16:28
NASDAQ TRADE HALT CONTINUES HALT NEWS PENDING AT 03:28 AM
ProPhase Labs, Advanced Biological Laboratories Sign Letter of Intent for Reverse Merger
MT Newswires Live  ·  12-19
ProPhase Labs, Advanced Biological Laboratories Sign Letter of Intent for Reverse Merger
BRIEF-ProPhase Labs Signs Non-Binding LOI For Proposed Reverse Merger With Advanced Biological Laboratories
Reuters  ·  12-19
BRIEF-ProPhase Labs Signs Non-Binding LOI For Proposed Reverse Merger With Advanced Biological Laboratories
Prophase Labs Inc: Under Deal, Abl Would Become Majority Owner of Combined Entity
THOMSON REUTERS  ·  12-19
Prophase Labs Inc: Under Deal, Abl Would Become Majority Owner of Combined Entity
Prophase Labs: Proposed Deal Envisions That Abl Shareholders Would Own About 76% of Combined Co at Closing
THOMSON REUTERS  ·  12-19
Prophase Labs: Proposed Deal Envisions That Abl Shareholders Would Own About 76% of Combined Co at Closing
Prophase Labs Inc: Under Loi, May Declare a Special Cash Dividend of up to $10 Mln
THOMSON REUTERS  ·  12-19
Prophase Labs Inc: Under Loi, May Declare a Special Cash Dividend of up to $10 Mln
Prophase Labs Inc: Proposed Deal for May Imply an Enterprise Value of up to Approximately $30 Mln
THOMSON REUTERS  ·  12-19
Prophase Labs Inc: Proposed Deal for May Imply an Enterprise Value of up to Approximately $30 Mln
Prophase Labs Signs Non-Binding Loi for Proposed Reverse Merger With Advanced Biological Laboratories
THOMSON REUTERS  ·  12-19
Prophase Labs Signs Non-Binding Loi for Proposed Reverse Merger With Advanced Biological Laboratories
NASDAQ TRADE HALT HALT NEWS PENDING AT 06:55 AM
Reuters  ·  12-19
NASDAQ TRADE HALT HALT NEWS PENDING AT 06:55 AM
ABL Diagnostics and ProPhase Labs Sign Letter of Intent for Proposed Merger
Reuters  ·  12-19
ABL Diagnostics and ProPhase Labs Sign Letter of Intent for Proposed Merger
ProPhase Labs Amends Charter to Enact 1-for-10 Reverse Stock Split
Reuters  ·  12-19
ProPhase Labs Amends Charter to Enact 1-for-10 Reverse Stock Split
Prophase Labs Inc - Reverse Stock Split Effective December 22, 2025 - SEC Filing
THOMSON REUTERS  ·  12-13
Prophase Labs Inc - Reverse Stock Split Effective December 22, 2025 - SEC Filing
ProPhase Labs Files Amendment for 1-for-10 Reverse Stock Split
Reuters  ·  12-13
ProPhase Labs Files Amendment for 1-for-10 Reverse Stock Split
ProPhase Labs Inc. Held Special Shareholder Meeting
Reuters  ·  11-27
ProPhase Labs Inc. Held Special Shareholder Meeting
Join ProPhase Labs’ Exclusive Live Investor Webinar and Q&A Session on December 1
GlobeNewswire  ·  11-26
Join ProPhase Labs’ Exclusive Live Investor Webinar and Q&A Session on December 1
BRIEF-Prophase Labs- On Nov 21, Received Confirmation From Avtech Agreeing To Continue Its Forbearance Under Co's Existing Equipment Lease
Reuters  ·  11-26
BRIEF-Prophase Labs- On Nov 21, Received Confirmation From Avtech Agreeing To Continue Its Forbearance Under Co's Existing Equipment Lease
BRIEF-Prophase Labs - Aware That Civil Action Pending In The United States District Court For The Eastern District Of New York Has Been Unsealed
Reuters  ·  11-26
BRIEF-Prophase Labs - Aware That Civil Action Pending In The United States District Court For The Eastern District Of New York Has Been Unsealed
Prophase Labs- Under Avtech's Updated Payment Schedule, Co to Make Weekly Payments Beginning Nov 28, Until Outstanding Past-Due Amounts Are Current
THOMSON REUTERS  ·  11-26
Prophase Labs- Under Avtech's Updated Payment Schedule, Co to Make Weekly Payments Beginning Nov 28, Until Outstanding Past-Due Amounts Are Current
Prophase Labs Inc - Remains in Communication With Avtech Regarding These Payments
THOMSON REUTERS  ·  11-26
Prophase Labs Inc - Remains in Communication With Avtech Regarding These Payments
Prophase Labs - Aware That Civil Action Pending in the United States District Court for the Eastern District of New York Has Been Unsealed
THOMSON REUTERS  ·  11-26
Prophase Labs - Aware That Civil Action Pending in the United States District Court for the Eastern District of New York Has Been Unsealed

Introduction

Company Name.
ProPhase Labs
Affiliated Markets:
NASDAQ
Listing Date:
--
Main Business:
ProPhase Labs, Inc. develops and commercializes novel drugs, dietary supplements, and compounds in the United States. It operates through two segments: Diagnostic Services and Consumer Products. The company provides a range of TK supplements, including Legendz XL for male sexual health; and Triple Edge XL, an energy and stamina booster. It offers contract manufacturing services, such as product development, pre-commercialization, production, warehousing, and distribution; COVID-19 diagnostic information services to a range of customers, including health plans, third party payers, and government organizations; and respiratory pathogen panel molecular and DNA testing services, as well as personal genomics products and services. In addition, the company involved in the research, development, manufacture, distribution, marketing, and sale of over the counter (OTC) consumer healthcare products and dietary supplements; and retail operations. The company was formerly known as The Quigley Corporation. ProPhase Labs, Inc. was founded in 1989 and is headquartered in Garden City, New York.
Issue price:
--